168 HR donepezil 0.208 MG/HR Transdermal System [Adlarity]

RxNorm concept 2597453, branded drug (sbd). Prescribable name: Adlarity 5 MG/Day Weekly Transdermal System.

RxCUI: 2597453
Term type: Branded drug (SBD)
Status: Active

Request

curl https://api.healthcare.dev/v1/drugs/rxnorm/2597453 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

donepezil 135447

Other names

168 HR Adlarity 0.208 MG/HR Transdermal System

Related concepts

donepezil 0.208 MG/HR (SCDC, consists of)
donepezil 0.208 MG/HR [Adlarity] (SBDC, consists of)
Transdermal System (DF, has dose form)
Adlarity (BN, has ingredient)
168 HR donepezil 0.208 MG/HR Transdermal System (SCD, tradename of)

Linked data

NDCs

65038005501
65038005503

NDC-11s RxNorm links to this concept; linked ones open their FDA product.

Use it

Look up 2597453 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/rxnorm/2597453 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up RxNorm concept 2597453. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Get a free key RxNorm docs Connect the MCP server

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.